Bva-100
Payments companies reported to CMS as associated with Bva-100. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bva-100, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bva-100
These are the largest totals companies reported as associated with Bva-100. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marc Silver | Chandler, AZ | Cardiovascular Disease | $156,000.00 |
| Marc Silver | Raleigh, NC | Clinical Cardiac Electrophysiology | $86,128.40 |
| Jeffrey Johnson | Knoxville, TN | Cardiovascular Disease | $42,055.38 |
| Dmitry Yaranov | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $36,147.28 |
| Kevin Chung | Seattle, WA | Internal Medicine | $35,200.00 |
| John Strobeck | Staten Island, NY | Cardiovascular Disease | $33,192.60 |
| Robert Mirsky | Tampa, FL | Family Medicine | $30,003.75 |
| Sandra Sieck | La Crosse, WI | Internal Medicine | $17,023.70 |
| John Jefferies | Memphis, TN | Advanced Heart Failure and Transplant Cardiology | $15,494.01 |
| Marat Fudim | Durham, NC | Cardiovascular Disease | $12,000.00 |
Prescribed Bva-100?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.